Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Aporphine and isoquinoline derivatives block glioblastoma cell stemness and enhance temozolomide cytotoxicity ; volume:12 ; number:1 ; day:7 ; month:12 ; year:2022 ; pages:1-17 ; date:12.2022
Scientific reports ; 12, Heft 1 (7.12.2022), 1-17, 12.2022
- Urheber
-
Rodrigues-Junior, Dorival Mendes
Raminelli, Cristiano
Hassanie, Haifa
Trossini, Gustavo Henrique Goulart
Perecim, Givago Prado
Caja, Laia
Moustakas, Aristidis
Vettore, André Luiz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-25534-2
- URN
-
urn:nbn:de:101:1-2023021721013098815047
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rodrigues-Junior, Dorival Mendes
- Raminelli, Cristiano
- Hassanie, Haifa
- Trossini, Gustavo Henrique Goulart
- Perecim, Givago Prado
- Caja, Laia
- Moustakas, Aristidis
- Vettore, André Luiz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Accelerated hyperfractionation plus temozolomide in glioblastoma
Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres
Enhancing glioblastoma cytotoxicity through encapsulating O6-benzylguanine and temozolomide in PEGylated liposomal nanocarrier: an in vitro study
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
One-carbon-mediated purine synthesis underlies temozolomide resistance in glioblastoma
Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide
Accelerated hyperfractionation plus temozolomide in glioblastoma
Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres
Enhancing glioblastoma cytotoxicity through encapsulating O6-benzylguanine and temozolomide in PEGylated liposomal nanocarrier: an in vitro study
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
One-carbon-mediated purine synthesis underlies temozolomide resistance in glioblastoma
Glioblastoma stem cells deliver ABCB4 transcribed by ATF3 via exosomes conferring glioblastoma resistance to temozolomide
Accelerated hyperfractionation plus temozolomide in glioblastoma
Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres
Enhancing glioblastoma cytotoxicity through encapsulating O6-benzylguanine and temozolomide in PEGylated liposomal nanocarrier: an in vitro study
PPAR-γ agonists reactivate the ALDOC-NR2F1 axis to enhance sensitivity to temozolomide and suppress glioblastoma progression
Temozolomide promotes genomic and phenotypic changes in glioblastoma cells
p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiforme
Considering the experimental use of temozolomide in glioblastoma research
Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
Inhibition of gap junctions sensitizes primary glioblastoma cells for temozolomide
One-carbon-mediated purine synthesis underlies temozolomide resistance in glioblastoma